Type 2-diabetes - Sundhedsstyrelsen

tion in diabetic patients: a consequence of a multidisciplinary foot care team approach?.
Diabet Med 1995; 12(9):770-776.
516
Gottrup F, Holstein P, Jorgensen B, Lohmann M, Karlsmar T. A new concept of a multidisciplinary
wound healing center and a national expert function of wound healing. Arch
Surg 2001; 136(7):765-772.
517
Tennvall GR, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with
diabetes mellitus. Pharmacoeconomics 2000; 18(3):225-238.
518
Meenan RT, Stevens VJ, Hornbrook MC, La Chance PA, Glasgow RE, Hollis JF et al. Costeffectiveness
of a hospital-based smoking cessation intervention. Med Care 1998;
36(5):670-678.
519
Croghan IT, Offord KP, Evans RW, Schmidt S, Gomez-Dahl LC, Schroeder DR et al. Costeffectiveness
of treating nicotine dependence: the Mayo Clinic experience. Mayo Clin
Proc 1997; 72(10):917-924.
520
Kristensen JK. Data fra projektet ‘Monitorering af type 2 diabetes population i Århus
Amt‘. 2002
521
Kristensen JK. Identification of the Type 2 diabetes population in a Danish county and
evaluation of the performed care in a five-year period. Aarhus University, 2000.
522
Rissanen A, Pekkarinen T, Heinanen T. Weight loss with sibutramine in obese patients
with type 2 diabetes: a double-blind, placebo-controlled study. Obes.Res. 7, 93S. 1999
523
Serrano-Rios M, Melchionda N, Moreno-Carretero E. Role of sibutramine in the treatment
of obese Type 2 diabetic patients receiving sulphonylurea therapy. Diabet Med
2002; 19(2):119-124.
524
Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE et al. Weight loss with
sibutramine improves glycaemic control and other metabolic parameters in obese
patients with type 2 diabetes mellitus. Diabetes Obes Metab 2000; 2(3):175-187.
525
Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J. Sibutramine is effective for weight
loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind,
placebo-controlled study. Diabetes Obes Metab 2000; 2(2):105-112.
526
McNulty SJ, Ur E, Williams G. A randomized trial of sibutramine in the management of
obese type 2 diabetic patients treated with metformin. Diabet Care 2003; 26(1):125-131.
527
Gokcel A, Karakose H, Ertorer EM, Tanaci N, Tutuncu NB, Guvener N. Effects of sibutra-
TYPE 2-DIABETES – Medicinsk teknologivurdering af screening, diagnostik og behandling 377